Neutralisation of the anti-coagulant effects of heparin by histones in blood plasma and purified systems.
Longstaff C, Hogwood J, Gray E, Komorowicz E, Varjú I, Varga Z, Kolev K.
Thromb Haemost. 2016 Mar;115(3):591-9. doi: 10.1160/TH15-03-0214. Epub 2015 Dec 3.
PMID:26632486
Complexation of a poly-L-arginine with low molecular weight heparin enhances pulmonary absorption of the drug.
Rawat A, Yang T, Hussain A, Ahsan F.
Pharm Res. 2008 Apr;25(4):936-48. doi: 10.1007/s11095-007-9442-x. Epub 2007 Oct 23.
PMID:17955186
Relationship between ex vivo anti-proteinase (factor Xa and thrombin) assays and in vivo anticoagulant effect of very low molecular weight heparin, CY222.
Tew CJ, Lane DA, Thompson E, Ireland H, Curtis JR.
A prophylactic subcutaneous dose of the anticoagulant tinzaparin does not influence qPCR-based assessment of circulating levels of miRNA in humans.
Nilsson A, Nerhall AM, Vechetti I, Fornander L, Wiklund S, Alkner B, Schilcher J, von Walden F.
PLoS One. 2022 Nov 3;17(11):e0277008. doi: 10.1371/journal.pone.0277008. eCollection 2022.
PMID:36327247
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia.
Kern PA, Martin RA, Carty J, Goldberg IJ, Ong JM.
J Lipid Res. 1990 Jan;31(1):17-26.
PMID:2313202
Simvastatin ameliorates deep vein thrombosis in rabbits by regulating the fibrinolytic system.